Abstract

Skin sensitivity, scientifically called Irritable Skin Syndrome (ISS), is one of the main disturbing skin conditions and remains a growing global concern. Symrise R&D has developed specific cosmetic actives to fight the different physiological reactions that lead to skin discomfort related to the ISS. Each benefit is documented by a clinical study.
SymCalmin® (INCI name: Butylene Glycol, Pentylene Glycol, Hydroxyphenyl Propamidobenzoic Acid) effectively reduces skin itchiness and redness. While SymSitive® 1609 (INCI: Pentylene Glycol, 4-t-Butylcyclohexanol) relieves burning & stinging sensations. And to complete these two actions, recently-launched SymReboot™ L19 (INCI: Maltodextrin, Lactobacillus Ferment) restores and strengthens the skin’s barrier integrity to reduce Trans Epidermal Water Loss (TEWL) and visible signs of dryness.
These three complementary cosmetic actives soothe the skin hypersensitivity by restoring the skin homeostasis.